Hideaki Nagai - Concepedia

Author

Hideaki Nagai

Also Known As

H Nagai, Hideaki NAGAI, Hideaki Nagai, Kosuke Yoshida, Nagai Hideaki, Naoya Ichimura, Nobukazu Fujimoto, Osamu Narumoto, Yoshito Takeda, 永井英明

203

Publications

Citations

H-Index

Concepts

All Affiliations

Tokyo National Hospital Japan Anti Tuberculosis Association Nagasaki University Fukujuji Hospital National Hospital Organization

About

Hideaki Nagai is an author at Tokyo National Hospital specializing in medicine, tuberculosis, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	27	897
2	Health Sciences	4	4	299
3	Engineering	2	2	87
4	Public Health	2	2	29
5	Nursing	1	1	16

Hideaki Nagai

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Long-Term Low-Dose Administration of Erythromycin to Patients with Diffuse Panbronchiolitis Hideaki Nagai, Harumi Shishido, Ryozo Yoneda, Respiration Antimicrobial SusceptibilityAllergyAntibioticsDiffuse PanbronchiolitisHealth Sciences	1991	247
Clinical and Microbiological Differences between Mycobacterium abscessus and Mycobacterium massiliense Lung Diseases Toshiyuki Harada, Yasushi Akiyama, Atsuyuki Kurashima, Journal of Clinical Microbiology Pathogenic MicrobiologyPathologyMedical MicrobiologyRespiratory InfectionInfection Control	2012	170
Assessment of sleep disturbance in lung cancer patients: Relationship between sleep disturbance and pain, fatigue, quality of life, and psychological distress Mare Nishiura, Atsuhisa Tamura, Hideaki Nagai, Palliative & Supportive Care	2014	140
Evaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan Lina Yi, Yuka Sasaki, Hideaki Nagai, Scientific Reports	2016	85
Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection Maho Suzukawa, Shunsuke Akashi, Hideaki Nagai, PLoS ONE	2016	72
Development of polybenzimidazole modification with open-edges/porous-reduced graphene oxide composite membranes for excellent stability and improved PEM fuel cell performance Keiichiro Maegawa, Hideaki Nagai, Rajesh Kumar, Materials Chemistry and Physics Materials ScienceGraphene NanomeshesChemical EngineeringCatalytic MembraneEngineering	2022	72
A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-resistant Pathogens to Select Initial Empiric Therapy Takaya Maruyama, Takao Fujisawa, Tadashi Ishida, Clinical Infectious Diseases	2018	55
Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective Keiko Konomura, Hideaki Nagai, Manabu Akazawa Pneumonia	2017	54
Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease Tsukasa Kadota, Hirotoshi Matsui, Takashi Hirose, BMC Infectious Diseases	2015	52
The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force Qingbo S. Wang, Ryuya Edahiro, Ho Namkoong, Nature Communications	2022	48

Page 1